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Taspase1, a highly conserved threonine protease encoded by TASP1, cleaves nuclear histonemodifying factors and basal transcription regulators to orchestrate diverse transcription programs.
Hereditary loss-of-function mutation of TASP1 has recently been reported in humans as resulting
in an anomaly complex syndrome, which manifests with hematological, facial, and skeletal
abnormalities. Here, we demonstrate that Taspase1-mediated cleavage of TFIIAα-β, rather than
of MLL1 or MLL2, in mouse embryos was required for proper fetal liver hematopoiesis and correct
segmental identities of the axial skeleton. Homozygous genetic deletion of Taspase1 disrupted
embryonic hematopoietic stem cell self-renewal and quiescence states and axial skeleton fates.
Strikingly, mice carrying knockin noncleavable mutations of TFIIAα-β, a well-characterized basal
transcription factor, displayed more pronounced fetal liver and axial skeleton defects than those
with noncleavable MLL1 and MLL2, 2 trithorax group histone H3 trimethyl transferases. Our study
offers molecular insights into a syndrome in humans that results from loss of TASP1 and describes
an unexpected role of TFIIAα-β cleavage in embryonic cell fate decisions.
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Recently, a novel human hereditary anomaly syndrome was recognized in association with loss-of-function
mutations in the TASP1 gene (1–3). Those patients were characterized with microcephaly, developmental
delay, distinctive facial features, and other anomalies, including anemia, thrombocytopenia, and lymphocytopenia (2, 3). TASP1 codes for Taspase1, which is an evolutionarily conserved threonine protease that
cleaves and regulates nuclear proteins, most notably, MLL (KMT2A, also known as MLL1) and TFIIAα-β
(4–6). Taspase1 is a 50 kD α-β proenzyme that undergoes intramolecular autoproteolysis to produce mature,
active α28/β22 heterodimeric protease (4, 6–8). Cleavage of Taspase1 substrates occurs distal to the aspartate residue within the conserved IXQL(V)D/G motif (4, 9).
The bona fide Taspase1 substrates are MLL1, MLL2 (also known as KMT2B), TFIIAα-β (also known
as GTF2A1), ALF (TFIIA-like factor, also known as GTF2A1L) and Drosophila HCF (dHCF) (4, 5, 10–
12). MLL1, a member of the trithorax group (Trx-G) epigenetic modifiers, is a histone methyl transferase
(HMT) that trimethylates H3 at lysine 4, generating a histone mark of active transcription (13, 14). In
the absence of proteolytic activation, immature MLL1 polypeptide displays reduced HMT activity and,
hence, functions as a hypomorphic mutant (11). TFIIA, comprising 3 polypeptides (α, β, and γ), complexes
with TATA-binding protein (TBP) and constitutes an integral part of the basal transcription machinery
(15–19). Precursor TFIIAα-β, encoded by a single gene, Gtf2a1, is processed into TFIIAα and -β subunits
by Taspase1-mediated cleavage (5). Complexes of TFIIAα-β/γ containing noncleaved TFIIAα-β have transcriptional activity in vitro, and its maturation into TFIIAα/β/γ increases its susceptibility to regulatory
degradation (5). In addition, TFIIAα-β/γ and TFIIAα/β/γ are different in the pattern of interactions with
TFIID, an important factor for promoter recognition (20). Since TBP-like protein was reported to be a negative regulator of the Taspase1-mediated processing of TFIIA, Taspase1 may fine-tune the transcription of
1

RESEARCH ARTICLE

genes through these factors (21). Previous studies revealed that the proteolytic cleavage of TFIIA is critical
for male spermiogenesis (22) and craniofacial development (23).
Taspase1-mediated cleavage of each substrate may account for various phenotypes of Taspase1 deficiency, or, alternatively, protease-independent biological activities of Taspase1 may exist. Here, we performed mouse genetic studies to interrogate the biological significance of cleavage of MLL1, MLL2, and
TFIIA. Taspase1-mediated cleavage of TFIIA has the most prominent effects on fetal hematopoiesis as
well as on the specification of axial skeleton, offering molecular insights concerning a syndrome in humans
that results from loss of TASP1.

Results
To investigate the physiological function of Taspase1, we generated Tasp1-deficient mice (Tasp1–/– mice).
Our initial report demonstrated that these animals displayed marked homeotic transformation of the axial
skeleton and a decrease in overall body size (11). Furthermore, Tasp1–/– mice die shortly after birth, partly
due to feeding defects (11). Here, we further examined the role of Taspase1 in embryogenesis and initiated
studies by comparing these Tasp1–/– and WT littermate embryos. Tasp1–/– E14.5 embryos show a severe
developmental retardation, reflected by an approximately 40% reduction in overall weight in comparison to
that of WT embryos (Figure 1A). Furthermore, Tasp1–/– embryos have markedly smaller fetal livers (Figure
1B). The decrease in fetal liver cell number was significant even after normalizing for reduced body weight
(P < 0.001) (Figure 1A).
We next analyzed the fetal liver for mature blood cell lineages and the hematopoietic stem and progenitor
cell compartments using multicolor flow cytometry. The analysis of E14.5 fetal livers showed that Tasp1–/–
and WT fetal livers had little difference in the populations of B220+ B cells, Gr-1+ granulocytes, and TER-119+
red blood cells (Figure 1C). In contrast, the stem and progenitor cell populations, marked by Lin–Sca-1+cKit+ staining (so-called LSK cells), were reduced in Tasp1–/– fetal livers (Figure 1, D and E). LSK cells can
be further specified as multipotent progenitor cells (MPPs; Lin–Sca-1+c-Kit+CD150–) or hematopoietic stem
cells (HSCs; Lin–Sca-1+c-Kit+CD150+) (24, 25). In Tasp1–/– fetal livers, the abundance of HSCs was found to
be reduced to approximately half that of the WT fetal liver (Figure 1E), resulting in an approximately 78%
decrease in the absolute number of HSCs (Figure 1F). No difference in the frequency of Lin–Sca-1–c-Kit+
myeloid progenitors was observed, whereas absolute numbers of these cells were decreased. Specifically, in
Tasp1–/– fetal livers, the relative abundance of common myeloid progenitors (CMPs), granulocyte-monocyte
progenitors (GMPs), and megakaryocyte-erythrocyte progenitors (MEPs) was normal (Figure 1, D and E).
Together, our data indicate that, in the mouse fetal liver, Taspase1 may be required for the development and
maintenance of the HSC compartment.
Accordingly, we investigated how Taspase1 loss leads to impaired fetal liver HSC renewal. Loss of
Taspase1 activity could lead to increased cell death and/or aberrant cell cycle control. Cell death analysis
of LSK cells and HSCs showed no increase of apoptosis in Tasp1–/– fetal livers (Figure 2A). On the other
hand, cell cycle analysis of MPPs and HSCs yielded a marked difference between WT and Tasp1–/– cells.
Most notably staining of DNA and RNA with 7-AAD and pyronin Y, respectively, showed that more
Tasp1–/– fetal liver HSCs exited stem cell quiescence, with decreased number of cells in the G0 phase, whereas the majority of WT HSCs were in the G0 phase, with fewer cells at G1 and S/G2/M (Figure 2, B and C).
In contrast, Tasp1–/– fetal liver MPPs displayed similar cell cycle profile as WT MPPs. Strikingly, the cell
cycle profile observed of Tasp1–/– fetal liver HSCs resembles that of MPPs (Figure 2B).
To elucidate by which substrate(s) cleavage of Taspase1 regulates fetal liver hematopoiesis, we
first focused on the MLL family proteins MLL1 and MLL2. MLL1 is the best-characterized Taspase1
substrate, controls Hox and Cylclin gene expression, and plays a critical role in both fetal and adult
hematopoiesis (26–28). Homozygous knockin of noncleavable (nc) Mll1 mutant alleles (Mll1nc/nc) at the
endogenous Mll1 locus did not reduce the overall fetal liver cellularity (Figure 3A) but incurred a minor
decrease in frequency and number of HSCs (Figure 3B). As published data suggest a partial redundancy
between Mll1 and Mll2 (11), we analyzed E14.5 fetal livers of Mll1nc/nc;2nc/nc embryos bearing homozygous knockin of nc Mll1 and nc Mll2 mutant alleles at their native genomic loci and did not detect
reduced fetal liver cellularity or body weight (Figure 3C). Similarly, the reduced abundance or absolute
number of HSCs in Mll1nc/nc;2nc/nc fetal livers was not statistically significant (Figure 3D).
TFIIA family proteins TFIIAα-β and ALF are the only bona fide mammalian Taspase1 substrates
known thus far besides MLL1 and MLL2. As expression of ALF is restricted to the mammalian testis (29),
JCI Insight 2021;6(15):e149382 https://doi.org/10.1172/jci.insight.149382
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Figure 1. Taspase1 deficiency results in fetal liver hematopoietic stem cell defects. (A) Body weight and cell numbers
of fetal livers (FLs) normalized to body weight of E14.5 embryos of the indicated WT and Taspase1-knockout (Tasp1–/–)
embryos. Boxes contain the 25th to 75th percentiles of data sets, with 50th percentile center lines, and whiskers mark the
5th and 95th percentiles. Outliers are shown by dots. (B) Images of E14.5 FLs of the indicated genotypes. Scale bar: 2 mm.
(C) Frequency of E14.5 FL cells committed to erythroid (TER-119+), myeloid (Gr-1+), and B cell (B220+) lineages. (D) Progenitor and stem cell analyses of E14.5 FL cells by flow cytometry. Lin–Sca-1+c-Kit+ cells are defined as LSK, and Lin–Sca-1–cKit+ cells as myeloid progenitors. Myeloid progenitors are subdivided into CMP, GMP, and MEP by CD34 and CD16/32. LSK
CD150+ cells are defined as HSCs. (E) Quantification of stem and progenitor cells of 15 WT and 12 Tasp1–/– FLs. (F) HSCs per
E14.5 FL of the indicated genotypes. Numbers were calculated by multiplying FL cellularity and HSC frequency. Data are
shown as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 by Mann-Whitney U test. HSC, hematopoietic stem cell;
CMP, common myeloid progenitor; GMP, granulocyte-monocyte progenitor; MEP, megakaryocyte-erythrocyte progenitor.

we focused on the noncleavage of TFIIAα-β. We have created a Gtf2a1nc/nc mouse model in which the endogenous D/G cleavage residues of TFIIAα-β are replaced with noncleavable A/A and have reported that
Gtf2a1nc/nc males are infertile (22). Remarkably, Gtf2a1nc/nc embryos were smaller than their WT littermates,
and their livers were disproportionally smaller (Figure 4, A and B). Furthermore, the frequencies of HSCs
in Gtf2a1nc/nc fetal livers were also reduced (Figure 4D). In fact, the absolute HSC number of Gtf2a1nc/nc fetal
livers was approximately 30% of that of their WT littermates (Figure 4E). Similar to Tasp1–/– embryos, there
were no significant changes in the frequency of myeloid progenitors, CMPs, GMPs, or MEPs in Gtf2a1nc/nc
fetal livers (Figure 4, C and D). Cell cycle analysis of Gtf2a1nc/nc fetal liver stem and progenitor cells demonstrated decreased a number of Gtf2a1nc/nc HSCs in the G0 phase, which is reminiscent to that of WT and
Gtf2a1nc/nc MPPs (Figure 5). The decrease in G0 phase and the coinciding increases in non-G0 phases of the
JCI Insight 2021;6(15):e149382 https://doi.org/10.1172/jci.insight.149382
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Figure 2. Tasp1–/– fetal liver hematopoietic stem cells exhibit an aberrant cell cycle profile reminiscent of multipotent progenitor cells. (A) Cell
death analysis quantified by annexin V staining. The frequency of annexin V+ cells in fetal liver (FL) hematopoietic stem cell (HSC) and LSK cells of
the indicated genotypes was displayed (WT, n = 3; Tasp1–/–, n = 5). Data are shown as the mean ± SEM. (B and C) Cell cycle analysis of FL HSCs and
multipotent progenitor cells (MPPs). Cells were stained with 7-AAD and pyronin Y to assess DNA and RNA contents, respectively. (B) The quadrant
gates of the representative plots based on DNA and RNA contents are outlined as G0, G1 and S/G2/M phases. (C) The frequency of HSCs and MPPs
in G0 and non-G0 (G1 and S/G2/M) phases. Data are shown as the mean ± SEM (n = 4 for all samples). P values of 4 independent experiments by χ2
testing were combined by the Fisher’s method; ***P < 0.001.

Gtf2a1nc/nc fetal liver HSCs indicated a stem cell quiescence defect similar to that observed in Tasp1–/– fetal liver HSCs (Figure 2, B and C). These striking similarities between Gtf2a1nc/nc and Tasp1–/– fetal livers highlight
the importance of the Taspase1-TFIIA axis in the maintenance of fetal liver HSCs.
To further investigate this potentially novel regulation, we employed stem cell transplant assays to evaluate the capacity of Tasp1–/– and Gtf2a1nc/nc fetal liver HSCs in long-term hematopoietic reconstitution. Competitive repopulation assays were performed by transplanting 150 CD45.2+ HSCs from WT, Tasp1–/–, or
Gtf2a1nc/nc E14.5 fetal livers along with CD45.1+ competitor cells into lethally irradiated CD45.1+ mice (Figure 6A). Twelve weeks after transplantation, peripheral blood was analyzed for the contribution of donor-derived HSCs to mature blood lineages, including B220+ for B cells, CD3+ for T cells, and Gr-1+Mac-1+ for
myeloid cells (Figure 6, B and C). More than 5% of CD45.2+ donor-derived cells in all 3 lineages were
detected in 13 of 19 mice transplanted with WT HSCs, whereas multilineage reconstitution was detected in
neither the 9 mice transplanted with Tasp1–/– HSCs nor the 8 mice transplanted with Gtf2a1nc/nc HSCs (Table
1). Thus, the Taspase1-TFIIA axis appears to be required for long-term reconstitution of hematopoietic cells
from fetal livers, suggesting its role in long-term HSC self-renewal.
The phenotypic similarities between Gtf2a1nc/nc and Tasp1–/– fetal liver HSCs indicate that TFIIA is the principal Taspase1 substrate conferring Taspase1-orchestrated fetal liver hematopoiesis.
As noncleaved TFIIAα-βnc is more stable than cleaved TFIIA (5, 22) and no apparent abnormalities
were detected in Gtf2a1nc/+ fetal livers (data not shown), TFIIAα-βnc is unlikely to function as a dominant-negative mutant in fetal liver hematopoiesis. Instead, data favors cleaved TFIIA positively regulating fetal liver hematopoiesis.
Hox genes of the vertebrates and homeotic genes of the invertebrates play critical roles in implementing body plan, and their deregulation results in the loss of segmental identities, i.e., homeotic transformation. As our previous studies demonstrated that Tasp1–/– mice exhibit homeotic transformation
(11), we examined the axial skeleton of Gtf2a1nc/nc newborn pups (n = 17) and detected overt homeotic
JCI Insight 2021;6(15):e149382 https://doi.org/10.1172/jci.insight.149382
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Figure 3. Hematopoietic stem cell quantification of Mll1nc/nc and Mll1nc/nc;2nc/nc fetal livers. (A and B) Embryos obtained
by intercrossing Mll1nc/+ mice were analyzed. (A) Body weight and normalized E14.5 fetal liver (FL) cellularity. (B) Frequency of hematopoietic stem cells (HSCs) and number of HSCs per FL (WT, n = 8; Mll1nc/nc, n = 8). (C and D) Embryos
obtained by intercrossing Mll1nc/nc;2nc/+ mice were analyzed. (C) Body weight and normalized E14.5 FL cellularity. (D)
Frequency of HSCs and number of HSCs per FL (Mll1nc/nc;2+/+, n = 6; Mll1nc/nc;2nc/nc, n = 10). Data are shown as the mean ±
SEM. P values were determined by Mann-Whitney U test.

transformations, including abnormal anterior arch of atlas (a.a.a.) (82%), split of C2 (cervical vertebra)
(18%), fusion of C3 to C5 (29%), posterior transformation of C7 (65%), anterior transformation of T8
(thoracic) (12%), incomplete ossification of sternebra 4 (65%), incomplete segmentation of sternebrae 3
and 4 (24%), and posterior transformation of L6 (lumbar) (53%) (Figure 7 and Table 2). Unexpectedly,
homeotic defects of Gtf2a1nc/nc newborns were more profound than those of Mll1nc/nc;2nc/nc newborns and
highly reminiscent of those of Tasp1–/– newborns (Figure 7 and Table 2). Homeotic transformation of the
axial skeletons is the defining feature of Hox gene deregulation (30, 31), and these extensive homeotic
defects in Gtf2a1nc/nc mice indicate a potentially novel regulation of Hox genes by TFIIA, a basal transcription factor, through a site-specific proteolytic process.

Discussion
Unlike most reversible posttranslational protein modifications, such as phosphorylation, acetylation, and
methylation, proteolysis through either degradation or site-specific cleavage renders structural changes permanent and, thereby, potentially results in long-lasting functional consequences. In metazoans,
site-specific proteolysis regulates critical aspects of biology, such as the activation of blood coagulation
factors for hemostasis, the activation of caspases for cell death execution, the cleavage of Notch intracellular domain for cell fate determination, the release of SREBP for cholesterol homeostasis (32), the maturation of HCF and MLL1 for cell cycle progression (11, 12), and the assembly of mature TFIIAα/β/γ
for male germ cell maturation (5, 22). Indeed, the identification and functional characterization of proteases and their cognate substrates have been instrumental in unraveling the underlying mechanisms
concerning diverse biological processes.
Taspase1 is a highly conserved protease that orchestrates a plethora of genetic programs through
cleaving nuclear transcription regulators, MLL1, MLL2, TFIIA, ALF, and dHCF (6, 33). Given that
TFIIA is a basal transcription factor and Hox genes are highly specialized transcription factors, the
JCI Insight 2021;6(15):e149382 https://doi.org/10.1172/jci.insight.149382
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Figure 4. Gtf2a1nc/nc hematopoietic stem cells exhibit
overt fetal liver hematopoiesis
defects. (A) Body weight and
normalized fetal liver (FL) cellularity of 19 WT and 27 Gtf2a1nc/nc
E14.5 FLs. Boxes contain the
25th to 75th percentiles of data
sets, with 50th percentile center
lines, and whiskers mark the 5th
and 95th percentiles. Outliers
are shown by dots. ***P < 0.001
by Mann-Whitney U test. (B)
Images of E14.5 FLs of the indicated WT and Gtf2a1nc/nc
embryos. Scale bar: 2 mm.
(C and D) Quantification of
hematopoietic stem and progenitor cells of E14.5 FLs by flow
cytometry. (C) Representative
dot plots. (D) The frequency of
stem and progenitor cells in FLs.
(E) The number of hematopoietic stem cells (HSCs) per FL.
Data are shown as the mean ±
SEM. **P < 0.01, ***P < 0.001 by
Mann-Whitney U test (WT, n =
6; Gtf2a1nc/nc, n = 8).

connections between Taspase1-mediated proteolytic processing of TFIIA and transcriptional regulation of Hox genes were completely unexpected, adding an additional layer of complexity to the
intricate control of Hox gene expression through upstream transcription factors, epigenetic regulators,
and long intergenic noncoding RNA (34, 35) for constructing segmental body plan and specifying cell
lineages including stem cells.

Figure 5. Aberrant cell cycle
profile of Gtf2a1nc/nc hematopoietic stem cells. Cell cycle
analysis of Gtf2a1nc/nc E14.5 fetal
liver (FL) hematopoietic stem
cells (HSC) and multipotent
progenitor cells (MPPs). (A) The
quadrant gates defining G0, G1,
and S/G2/M phases. (B) The
frequency of HSCs and MPPs in
G0 and non-G0 (G1 and S/G2/M)
phases. Data are shown as the
mean ± SEM (n = 4 for all samples). P values of 4 independent
experiments by χ2 testing were
combined by the Fisher’s method; **P < 0.01.
JCI Insight 2021;6(15):e149382 https://doi.org/10.1172/jci.insight.149382
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Figure 6. Tasp1–/– and
Gtf2a1nc/nc fetal liver
hematopoietic stem
cells fail to reconstitute
lethally irradiated recipient
mice. (A) Outline of the
experimental design of
long-term competitive
repopulation assays. (B)
Scatterplots showing the
frequency of donor-derived
B cell (B220+), T cell (CD3+)
and myeloid (Gr-1+Mac-1+)
lineages reconstituted at
12 weeks after transplant.
Data are shown as the
average ± SEM. WT, n = 19;
Tasp1–/–, n = 9; Gtf2a1nc/nc,
n = 8. (C) Representative
plots show reconstitution
by donor hematopoietic
stem cells (HSCs) of the
indicated genotypes in B
cell, T cell, and myeloid
lineages assessed 12
weeks after transplant. In
each lineage, CD45.2+ and
CD45.1+ cells were derived
from donor (WT, Tasp1–/– or
Gtf2a1nc/nc) and competitor
cells, respectively. See also
Table 1.

The paradigm of Taspase1 function provides an opportunity to investigate how proteases interconnect diverse genetic programs via site-specific proteolysis. In the absence of Taspase1-mediated cleavage, MLL1, MLL2, and TFIIAα-β retain partial activity and animals bearing noncleaved
MLL1, MLL2, and/or TFIIAα-β manifest hypomorphism in several biological settings (11, 22, 36,
37). Consequently, the alleles encoding nc MLL1, MLL2, and TFIIAα-β differ from null alleles and
thus provide invaluable insight in cases where genetic ablation results in early embryonic lethality.
Likewise, Taspase1 deficiency appears to offer a unique opportunity to uncover signaling pathways

Table 1. Multilineage reconstitution from WT, Tasp1–/–, or Gtf2a1nc/nc donor HSCs
Donor HSC genotype

Multilineage reconstitution

WT
Tasp1–/–
Gtf2a1nc/nc

13/19
0/9A
0/8B

The number of mice in which multilineage reconstitution was detected per group is shown. AP < 0.001, BP < 0.01 by the
Fisher’s exact test (versus WT). HSCs, hematopoietic stem cells.

JCI Insight 2021;6(15):e149382 https://doi.org/10.1172/jci.insight.149382
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Figure 7. Homeotic transformation of axial skeletons in Tasp1–/–, Gtf2a1nc/nc, and Mll1nc/nc;2nc/nc newborns. Lateral
views of cervical (C1–C7) and upper thoracic (T1) regions demonstrate deformed anterior arch of atlas (C1) and fusion
of C3–C4 (asterisks) in the Tasp1–/– and Gtf2a1nc/nc skeleton and posterior transformation of C7 with an additional rib
(arrowheads) in Tasp1–/–, Gtf2a1nc/nc, and Mll1nc/nc;2nc/nc skeleton (top row). Anterior views of the chest indicate incomplete ossification of sternebrae 4 (arrowheads) in Tasp1–/– and Gtf2a1nc/nc newborns and incomplete segmentation of
sternebrae 3–4 (asterisks) in Mll1nc/nc;2nc/nc newborns (middle row). Anterior views of lower thoracic and lumbar vertebrae
(L1–L6) demonstrate anterior transformation of L1 with an additional rib (arrowhead) in Tasp1–/– newborns and posterior
transformation of L6 in Gtf2a1nc/nc newborns. See also Table 2.

controlled by developmentally essential genes. Taspase1 regulates the cell cycle, axial skeletal formation, fetal HSC homeostasis, male germ cell development (11, 22, 36, 37), and craniofacial development (23). As TFIIA complexes with not only TBP but also TRF2 (a male germ cell–enriched
TBP variant) and TRF3 (a vertebrate-specific TBP variant), the Taspase1-TFIIA axis is positioned to
orchestrate the assembly of diverse tissue-specific or context-dependent transcription machinery that
are crucial for organismal development.

Methods
Mice. Tasp1–/–, Mll1nc/nc, Mll2nc/nc, and Gtf2a1nc/nc mice have been previously described (11, 22). Tasp1+/– and
Gtf2a1nc/+ mice were backcrossed to the WT C57BL6/J strain for 6 generations. Mll1nc/nc and Mll2nc/nc mice
were similarly backcrossed to the WT C57BL6/J strain for 10 generations.
Flow cytometric analyses of hematopoietic cells. To obtain single-cell suspensions of hematopoietic cells,
fetal livers were removed from E14.5 mouse embryos and homogenized by 3 passages through a 21-gauge
needle. Freed cells were filtered through a nylon mesh with a pore size of 40 μm. Collected cells were
treated with Red Blood Cell Lysing Buffer (MilliporeSigma) and then washed and filtered through nylon
mesh. Automated blood cell counting was performed using a Hemavet Blood Analyzer (Drew Scientific).
For mature blood cell analyses, 1 million cells were stained using the following antibodies: B220 APC
(RA3-6B2) (BD Biosciences), Gr-1 PE (RB6-8C5) (BD Biosciences), and TER-119 Pacific Blue (TER-119)
(BioLegend). For analyses of stem and progenitor cells, 1 million cells were stained using a combination of
following antibodies: Lin (lineage antibody cocktail from BioLegend: CD3 [17A2], CD4 [GK1.5], CD8α
[53-6.7], B220 [RA3-6B2], TER-119 [TER-119], and Gr-1 [RB6-8C5]) Pacific Blue (BioLegend), Sca-1 PE
(D7) (BD Biosciences), c-Kit APC/Alexa Fluor 750 (2B8) (BD Biosciences), CD34 FITC (RAM34) (BD
Biosciences), CD16/32 Alexa Fluor 647 (clone 93) (eBioscience), and CD150 PE/Cy7 (TC15-12F12.2)
(BioLegend). To identify and exclude dead cells, 7-AAD was added in the final suspension. Cells positive
JCI Insight 2021;6(15):e149382 https://doi.org/10.1172/jci.insight.149382
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Table 2. Skeletal defects observed in Tasp1–/–, Gtf2a1nc/nc, and Mll1nc/nc;2nc/nc newborns
Skeletal defects

a.a.a., tilted, broadened, and deformed
C2, split neural arch
C3-5, fusion
C7, posterior transformation
T8, anterior transformation
Sternebrae 4, incomplete ossification
Sternebrae 3 and 4, incomplete segmentation
L1, anterior transformation
L6, posterior transformation

WT (n = 14)

Tasp1–/– (n = 17)

Gtf2a1nc/nc (n = 17)

MLL1nc/nc;2nc/nc (n = 10)

14% (2)
0% (0)
0% (0)
0% (0)
0% (0)
0% (0)
0% (0)
0% (0)
0% (0)

47% (8)
12% (2)
76% (13)
94% (16)
59% (10)
41% (7)
29% (5)
82% (14)
0% (0)

82% (14)
18% (3)
29% (5)
65% (11)
12% (2)
65% (11)
24% (4)
0% (0)
53% (9)

20% (2)
0% (0)
0% (0)
50% (5)
0% (0)
0% (0)
50% (5)
0% (0)
0% (0)

a.a.a., abnormal anterior arch of atlas.

for Sca-1, CD34, or CD150 were determined by fluorescence-minus-one controls. Cells were analyzed with
an LSRFortessa flow cytometer (BD Biosciences). Dot plots and histograms were made with FlowJo software. Graphs and statistical analyses were prepared with GraphPad Prism 6.
Sorting of hematopoietic stem and progenitor cells. Single-cell suspensions were prepared from fetal
livers of E14.5 embryos or adult bone marrow and stained as described above. Fetal liver cells from
multiple littermate embryos of the same genotype were pooled to ensure sufficient number of cells for
staining. Stained cells were subsequently double sorted using a FACSAria II (BD Biosciences) to a
final purity of more than 95%.
Competitive reconstitution assay. C57BL6/J-CD45.1 mice were used as recipients and competitors.
The recipient mice were irradiated by 10 Gy divided into 2 fractions on the day –1. Competitor cells
were prepared from E14.5 fetal livers from the C57BL6/J-CD45.1 mice and frozen in advance. On day
0, LSK CD150+ HSCs were sorted from E14.5 fetal livers of donor embryos that express CD45.2. Each
recipient mouse was transplanted with 150 donor HSCs and 3 × 105 competitor fetal liver cells by tail
vein injection. After 12 weeks, peripheral blood and bone marrow cells of recipients were analyzed
for the presence of CD45.1+ and CD45.2+ cells by a LSRFortessa. Peripheral blood mononucleic cells
were stained with the following antibodies for analyzing myeloid lineage: CD45.1 PE (A20) (BD Biosciences), CD45.2 FITC (clone 104) (BD Biosciences), Mac-1 Ax647 (M1/70) (BD Biosciences), and
Gr-1 Pacific Blue (RB6-8C5) (BioLegend). The following antibodies were used for lymphoid lineage:
CD45.1 PE (A20), CD45.2 FITC (clone 104), B220 APC (RA3-6B2), and CD3 Pacific Blue (17A2).
Cell cycle analysis. Suspensions of sorted hematopoietic stem and progenitor cells were fixed with ethanol overnight at 4°C, washed, and then resuspended in the house-made Nucleic Acid Staining Solution
(38). Cells were stained with 7-AAD at room temperature for 20 minutes, followed by pyronin Y staining
on ice for 15 minutes. Stained cells were analyzed by a LSRFortessa flow cytometer.
Annexin V assay. One million fetal liver cells were stained with the following antibodies: Lin Pacific
Blue, Sca-1 PE (D7), c-Kit APC/Ax750 (2B8), and CD150 PE/Cy7 (TC15-12F12.2). The cells were subsequently washed, stained with annexin V FITC (BioVision) and Propidium Iodide (MilliporeSigma), and
then analyzed by flow cytometry.
Skeletal studies. P1 newborns were sacrificed and stained using Alizarin red (MilliporeSigma) and
Alcian blue (MilliporeSigma) for bone and cartilage, respectively, as described previously (39).
Statistics. Statistical significance was evaluated using the Mann-Whitney U test for continuous variables,
unless otherwise specified. χ2 testing was performed on cell cycle analyses, and P values of independent
experiments were combined by the Fisher’s method. P values of less than 0.05 were considered significant.
Study approval. All animal work was performed in accordance to a protocol approved by the Institutional Animal Care and Use Committee of Memorial Sloan Kettering Cancer Center.
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